Literature DB >> 17894513

Biodegradable nanoparticle flocculates for dry powder aerosol formulation.

Lianjun Shi1, Carl J Plumley, Cory Berkland.   

Abstract

Uncontrolled agglomeration presents a formidable encumbrance to nanoparticle formulation as a dry powder for inhalation therapy. Spray-drying and freeze-drying of nanosuspensions has demonstrated some success in creating dry powders composed of agglomerated nanoparticles with appropriate aerodynamic properties. These controlled drying processes, however, may require an undesirable amount of excipient to maintain an active therapeutic while generating dry powders and may not offer the desired control over agglomerate size and aerosolizability. As a potential alternative approach, a method for flocculating nanoparticles in solution followed by freeze-drying is reported. Biodegradable poly(DL-lactic-co-glycolic acid) nanoparticles were self-assembled into flocs via electrostatic interactions between nanoparticles coated with oppositely charged polyelectrolytes. The size of the nanoparticle flocs was readily controlled by manipulating the mixing ratio of charged nanoparticles. Freeze-drying the flocculated nanoparticles produced dry powders exhibiting low density (approximately 0.1 g/cm3), a weblike morphology, and desirable aerodynamic properties suited for dry powder aerosols.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17894513     DOI: 10.1021/la7020098

Source DB:  PubMed          Journal:  Langmuir        ISSN: 0743-7463            Impact factor:   3.882


  11 in total

1.  Effect of particle shape on dry particle inhalation: study of flowability, aerosolization, and deposition properties.

Authors:  Meer Saiful Hassan; Raymond Wai Man Lau
Journal:  AAPS PharmSciTech       Date:  2009-10-29       Impact factor: 3.246

2.  Dry powdered aerosols of diatrizoic acid nanoparticle agglomerates as a lung contrast agent.

Authors:  Nashwa El-Gendy; Kristin L Aillon; Cory Berkland
Journal:  Int J Pharm       Date:  2010-03-07       Impact factor: 5.875

3.  Iodinated NanoClusters as an inhaled computed tomography contrast agent for lung visualization.

Authors:  Kristin L Aillon; Nashwa El-Gendy; Connor Dennis; Jeffrey P Norenberg; Jacob McDonald; Cory Berkland
Journal:  Mol Pharm       Date:  2010-08-02       Impact factor: 4.939

4.  Nanoparticle agglomerates of fluticasone propionate in combination with albuterol sulfate as dry powder aerosols.

Authors:  Nashwa El-Gendy; Warangkana Pornputtapitak; Cory Berkland
Journal:  Eur J Pharm Sci       Date:  2011-09-21       Impact factor: 4.384

5.  Pure insulin nanoparticle agglomerates for pulmonary delivery.

Authors:  Mark M Bailey; Eric M Gorman; Eric J Munson; Cory Berkland
Journal:  Langmuir       Date:  2008-12-02       Impact factor: 3.882

6.  Poly(D,L-lactide-co-glycolide) nanoparticle agglomerates as carriers in dry powder aerosol formulation of proteins.

Authors:  Laura J Peek; Lydia Roberts; Cory Berkland
Journal:  Langmuir       Date:  2008-08-05       Impact factor: 3.882

7.  Budesonide nanoparticle agglomerates as dry powder aerosols with rapid dissolution.

Authors:  Nashwa El-Gendy; Eric M Gorman; Eric J Munson; Cory Berkland
Journal:  J Pharm Sci       Date:  2009-08       Impact factor: 3.534

8.  Combination chemotherapeutic dry powder aerosols via controlled nanoparticle agglomeration.

Authors:  Nashwa El-Gendy; Cory Berkland
Journal:  Pharm Res       Date:  2009-05-05       Impact factor: 4.200

9.  Novel Thymoquinone Nanoparticles Using Poly(ester amide) Based on L-Arginine-Targeting Pulmonary Drug Delivery.

Authors:  Eman Zmaily Dahmash; Dalia Khalil Ali; Hamad S Alyami; Hussien AbdulKarim; Mohammad H Alyami; Alhassan H Aodah
Journal:  Polymers (Basel)       Date:  2022-03-08       Impact factor: 4.329

10.  Nanosized rods agglomerates as a new approach for formulation of a dry powder inhaler.

Authors:  Hf Salem; Me Abdelrahim; K Abo Eid; Ma Sharaf
Journal:  Int J Nanomedicine       Date:  2011-02-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.